All In Biotech

Drug Trial Radar · NCT02798120

P3 Long Term Safety Study of Once Daily SB204 in Acne

A Phase 3 Multi-Center, Open Label Study Evaluating the Long Term Safety of SB204 Once Daily in the Treatment of Acne Vulgaris

Last checked: Nov 19, 2026Latest source record: May 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

601

Actual

Start

May 12, 2016

Primary completion

Apr 2017

Study completion Apr 27, 2017

Sponsor

Lead sponsor
Novan, Inc.Industry
Sponsor type
Industry
Collaborators
Chiltern International Inc.
First posted
Jun 14, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 9 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, open label long-term safety (LTS) study to be conducted in approximately 600 subjects with acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

  • SB204 4%Drug

    Open label, topical SB204 4%

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects With Adverse Events Ongoing From Parent Study at Start of Study NI-AC303)Time frame: Baseline
  2. Number of Subjects With Treatment Emergent Adverse EventsTime frame: Week 40/End of Treatment

Locations

69 sites in 1 country. Site status is shown where the registry gives one.

  • CIL #138

    Birmingham, Alabama

  • CIL #218

    Mobile, Alabama

  • CIL #189

    Phoenix, Arizona

  • CIL #146

    Anaheim, California

  • CIL #139

    Cerritos, California

  • CIL #216

    Chula Vista, California

  • CIL #186

    Fresno, California

  • CIL #210

    Fresno, California

  • CIL #174

    Huntington Beach, California

  • CIL #213

    La Mesa, California

  • CIL #209

    Oceanside, California

  • CIL #190

    Sacramento, California

  • CIL #161

    San Diego, California

  • CIL #113

    San Diego, California

  • CIL #195

    Santa Ana, California

  • CIL #119

    Santa Monica, California

  • CIL #199

    Santa Rosa, California

  • CIL #103

    Boca Raton, Florida

  • CIL #208

    Hialeah, Florida

  • CIL #212

    Homestead, Florida

  • CIL #222

    Lauderdale Lakes, Florida

  • CIL #170

    Miami Lakes, Florida

  • CIL #204

    Miami Springs, Florida

  • CIL #172

    Orlando, Florida

  • CIL #185

    Ormond Beach, Florida

  • CIL #203

    Ormond Beach, Florida

  • CIL #110

    Pinellas Park, Florida

  • CIL #227

    Sanford, Florida

  • CIL #211

    South Miami, Florida

  • CIL #176

    St. Petersburg, Florida

  • CIL #152

    Tampa, Florida

  • CIL #229

    Tampa, Florida

  • CIL #144

    Tampa, Florida

  • CIL #153

    Wellington, Florida

  • CIL #116

    Newnan, Georgia

  • CIL #143

    Savannah, Georgia

  • CIL #175

    New Albany, Indiana

  • CIL #191

    Overland Park, Kansas

  • CIL #215

    Wichita, Kansas

  • CIL #117

    Louisville, Kentucky

Showing 40 of 69 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.